Assyro AI

FDA Orange Book · active-ingredient family

Tinidazole

Tinidazole is approved as 1 brand and 4 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.

Reference-listed drug:TINDAMAX · NDA 021618

1

Brand (NDA)

4

Generics (ANDA)

0

Listed patents

0

Exclusivity periods

Brand (NDA) products · tablet

ProductApplicantApplicationTEApproved
TINDAMAXRLD×2MISSION PHARMANDA 021618ABMay 17, 2004

Generic (ANDA) products (4)

ProductApplicantApplicationTEApproved
TINIDAZOLE×2EDENBRIDGE PHARMSANDA 203808ABAug 04, 2015
TINIDAZOLE×2UNIQUEANDA 202489ABOct 09, 2013
TINIDAZOLE×2CHARTWELL RXANDA 202044ABApr 30, 2012
TINIDAZOLE×2HIKMAANDA 201172Apr 30, 2012

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Tinidazole — frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.